Grant accelerates McMaster University, SQI Diagnostics effort to move infection testing innovation from lab to market

A new grant is helping McMaster engineers and a Toronto precision-medicine diagnostics company to get infection-testing technology to market while generating opportunities for students.

By Wade Hemsworth April 13, 2021

A new grant is helping McMaster engineers and a Toronto precision-medicine diagnostics company to get infection-testing technology to market while generating opportunities for students.

Expert Featured In This Story

Tohid Didar
Tohid Didar

Associate Professor

See Profile

A new grant is helping McMaster engineers and a Toronto precision-medicine diagnostics company to get infection-testing technology to market while generating opportunities for students.

Last year, a research group led by Tohid Didar of McMaster’s Faculty of Engineering, working with industry researchers from SQI Diagnostics Inc., developed and successfully tested a new material to help detect critical but elusive markers of illness.

Designed as a coating for the lining of test tubes and other surfaces, the smart surface innovation improves the ability of diagnostics sensors to detect and measure the presence of cytokines, proteins the body produces as part of its immune response, permitting more accurate measurement of infections, including COVID, and cancer.

“This technology could be very useful in future pandemics, allowing researchers and clinicians to detect and identify cytokines faster and at lower cost,” Didar says. “Having the chance to save lives would be so gratifying.”

Measuring the microscopic markers in complex fluids such as blood had been a challenge until the team was able to isolate them using a surface that repels all other materials except cytokines. Measuring their presence makes it easier to understand how the body is reacting, including overreactions called cytokine “storms”.

Didar and McMaster colleague Leyla Soleymani are working with SQI Diagnostics to scale up the technology for commercial production, after receiving a three-year, $900,000 Collaborative Research and Development grant from the Natural Sciences and Engineering Research Council of Canada.

The new detection method is being added to SQI’s existing technology to make it both more effective and more efficient to produce, with the eventual goal of seeking FDA and Health Canada approval for its clinical use.

Didar and SQI’s Chief Scientific Officer Eric Brouwer say such partnerships allow manufacturers to have access to leading-edge research and development and help new technologies through the often-difficult pathway to the marketplace.

“We are investing in the future,” Brouwer says. “We are a company that makes strategic investments in innovation.”

Working together creates opportunities for researchers – especially graduate students – to apply their skills and discoveries for use in the everyday world and opens the door to internships and other employment opportunities.

Brouwer says research and development across the field is increasingly shifting to university partnerships, which help companies such as SQI to improve their capacity for innovation, allowing them to be more competitive.

Two pages from a zine. Text on the left page reads:

Safer drug use site for women and gender-diverse people saves lives 

The key is wraparound supports for overall health and well-being, such as addiction counselling, peer support, legal services, hygiene and reproductive health supplies and housing services. 
From left: Jana Radosavljevic, Ebonee Lennord, and Zeinab Hosseinidoust

How McMaster research supports gender equity

From tackling systemic barriers in health care to developing real-world solutions to everyday needs, here are some of the ways researchers at McMaster are driving change around the world.
A person holds up a hand in refusal to a container of snacking peanuts.

Bacteria found in mouth and gut may help protect against severe peanut allergic reactions

A new study shows how gut bacteria influence how a person reacts to peanuts, a discovery that could help with predicting and potentially reducing life threatening anaphylaxis.